ALGN vs BDX Stock Comparison

Compare ALGN and BDX across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 11, 2026 market close· AIQ score gap 6 points
ALGN
Healthcare
vs
BDX
Healthcare
ALGN
Align Technology, Inc.
Leads
Price
$151
Day move
+0.07%
AIQ Score
54/100
Best edge
Quality
Sector
Healthcare
BDX
Becton, Dickinson and Company
Price
$178
Day move
+0.81%
AIQ Score
48/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between ALGN and BDX?

ALGN leads the current stock comparison as Align Technology, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Align Technology, Inc. vs Becton, Dickinson and Company

Data as of Sep 11, 2026· market close· Healthcare· Coverage 66/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

ALGN leads

ALGN leads by 6 AIQ points, primarily on Quality, having only recently taken the lead back from BDX.

Fragile: 3 of 6 evidence groups support ALGN, and the lead recently changed hands.

Evidence agreement: 3 of 6Comparison trend: Reversed
ALGN

Align Technology, Inc.

Leads
AIQ Score
54/100
AIQ Edge Score
7/10
BDX

Becton, Dickinson and Company

AIQ Score
48/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors ALGN over BDX, 54 versus 48 as of Sep 11, 2026. ALGN's advantage is driven primarily by stronger quality, while BDX holds the stronger momentum profile. ALGN also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor ALGN today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. ALGN lead: Reversed — BDX led by 5 AIQ points 30 sessions ago; ALGN now leads by 6.

Compare Align Technology, Inc. and Becton, Dickinson and Company across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price-return comparison using available daily close history.

ALGN
-78.8%
BDX
-31.8%

Total return comparison

Growth of $10,000

ALGN $2,121 · BDX $6,822

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare ALGN and BDX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ALGN advantage
0
BDX advantage
  • Quality70 vs 44
    ALGN +26
  • Momentum28 vs 37
    BDX +9
  • Risk Resilience49 vs 46
    Even
  • Value63 vs 63
    Even

3 of 6 evidence groups favor ALGN. ALGN’s edge is concentrated in quality; BDX keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.

ALGN0 AIQ

Largest factor move: Momentum +1

No new signals fired.

BDX-1 AIQ

Largest factor move: Momentum -3

New signals

  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon
  • RSI Oversold - Potential Bounce bullish, momentum, short horizon

ALGN's lead widened by 1 AIQ points in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — ALGN and BDX both carry a full feed there.

The central trade-off

ALGN (Align Technology, Inc.): the stronger current systematic profile, led by quality.

BDX (Becton, Dickinson and Company): the counter-case, on momentum, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ALGN

ALGN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

BDX

BDX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

BDX

BDX on the Momentum factor, by 9 points.

Lower downside

BDX

BDX carries the lower 1-month annualized volatility.

Analyst upside

ALGN

ALGN on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureALGNBDXNote
Implied upside to target+36.1%+4%ALGN has more room
Target dispersion+22.9%+27.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering48Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor ALGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreALGN54 vs 48
FundamentalsALGNon balancerevenue growth 1.5% vs 5.7%; EPS growth -4.4% vs 223.4%; TTM ROE 10.1% vs 3.8%; gross margin 66.5% vs 46.1%; operating margin 13.3% vs 9.8% — ALGN takes 3 of 5 decided legs, not all of them
ValuationEvenValue 63 vs 63
TechnicalsBDXPrice vs 50-day -11.3% vs 3.7%; vs 200-day -10.4% vs 2.9%
Risk ResilienceEvenRisk Resilience 49 vs 46
Analyst expectationsALGNTarget upside 36.1% vs 4%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ALGN and BDX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 6 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ALGN.

How the comparison changed

119 daily snapshots · May 4 Sep 10

ALGN lead: Reversed — BDX led by 5 AIQ points 30 sessions ago; ALGN now leads by 6.

May 4ALGN leads above the line · BDX leads belowSep 10
Today
ALGN +6
54 vs 48
7 sessions ago
BDX +1
54 vs 55
30 sessions ago
BDX +5
54 vs 59
90 sessions ago
ALGN +7
63 vs 56

The lead changed hands 8 times in this window, most recently on Sep 8 when ALGN moved ahead of BDX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ALGN

0 bullish / 3 bearish / 1 neutral

  • Death Cross Active bearish, trend, long horizon (0.42%)
  • Downtrend Structure Active bearish, trend, long horizon
  • ATR Expansion - Breakout Mode neutral, volatility, short horizon (3.68%)
BDXConflicted

3 bullish / 3 bearish, conflicted

  • Death Cross Active bearish, trend, long horizon (0.04%)
  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon

BDX is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ALGNNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.07%, AIQ 0 points).

BDXDivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +0.81%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BDX closes the Quality gap — currently 26 points behind, the largest single contributor to ALGN's edge.
  2. 2BDX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ALGN starts generating bearish momentum or trend signals.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ALGN leads on balance
MetricALGNBDX
Revenue growth (YoY)1.5%5.7%
EPS growth (YoY)-4.4%223.4%
Gross margin66.5%46.1%
Operating margin13.3%9.8%
Return on equity (TTM)10.1%3.8%
Debt to equity0.030.69

Performance

Split across windows
MetricALGNBDX
1 week (5 sessions)-5.3%-5.9%
1 month (20 sessions)-13.4%-3.9%
3 months (63 sessions)-11.6%19.4%
6 months (126 sessions)-13.8%8.1%
Year to date-3.5%-9.1%
1 year (252 sessions)10.1%-7.9%

Technicals

BDX has the stronger structure
MetricALGNBDX
RSI (14)36.128.5
ADX (14)21.639.6
Price vs 50-day-11.3%3.7%
Price vs 200-day-10.4%2.9%
Volatility (1M, annualized)34.8%23.1%

Risk

Split
MetricALGNBDX
Beta1.410.39
Sharpe ratio0.36-0.22
Sortino ratio0.61-0.27
Max drawdown-23.7%-33%
Current drawdown-23.7%-16%
Annualized volatility39.3%30.6%
Value at risk (95%)-3.6%-2.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ALGN or BDX?

On the Algovestiq AIQ Score, ALGN is the stronger of the two as of Sep 11, 2026, scoring 54 against BDX's 48. The edge comes from quality. BDX is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ALGN or BDX the better buy right now?

ALGN carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor ALGN over BDX?

The composite weights Quality, Value, Momentum and Risk Resilience. ALGN leads Quality by 26 points; BDX leads Momentum by 9 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ALGN or BDX?

Analyst price targets imply +36.1% upside for ALGN and +4% for BDX, so the Street currently favors ALGN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ALGN or BDX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ALGN or BDX?

BDX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ALGN or BDX?

BDX on the Momentum factor, by 9 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ALGN or BDX?

BDX is the more resilient of the two, so the other name carries the higher downside risk. BDX carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ALGN more profitable than BDX?

ALGN leads on the comparable margin measures — gross margin 66.5% vs 46.1%; operating margin 13.3% vs 9.8%; ttm roe 10.1% vs 3.8%.

Is ALGN's lead over BDX getting stronger or weaker?

ALGN lead: Reversed — BDX led by 5 AIQ points 30 sessions ago; ALGN now leads by 6. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 8 times in that window, most recently on 2026-09-08, when ALGN moved ahead of BDX.

What would change the ALGN vs BDX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BDX closes the Quality gap — currently 26 points behind, the largest single contributor to ALGN's edge; BDX's Death Cross Active resolves — a bearish trend rule currently active against it; ALGN starts generating bearish momentum or trend signals; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about ALGN and BDX?

ALGN: 0 bullish / 3 bearish / 1 neutral. BDX: 3 bullish / 3 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ALGN is Death Cross Active (bearish, long horizon). On BDX it is Death Cross Active (bearish, long horizon).

Compare ALGN and BDX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.